These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
378 related articles for article (PubMed ID: 12150309)
1. Fixed-dose versus adjusted-dose warfarin in patients with prosthetic heart valves in a peri-urban impoverished population. Buchanan-Leel B; Levetan BN; Lombard CJ; Commerford PJ J Heart Valve Dis; 2002 Jul; 11(4):583-92; discussion 593. PubMed ID: 12150309 [TBL] [Abstract][Full Text] [Related]
2. Comparison of the efficacy and safety profiles of intravenous vitamin K and fresh frozen plasma as treatment of warfarin-related over-anticoagulation in patients with mechanical heart valves. Yiu KH; Siu CW; Jim MH; Tse HF; Fan K; Chau MC; Chow WH Am J Cardiol; 2006 Feb; 97(3):409-11. PubMed ID: 16442406 [TBL] [Abstract][Full Text] [Related]
3. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience]. Míka P; Behounek J; Skoták M; Nevsímal L Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102 [TBL] [Abstract][Full Text] [Related]
4. [Anticoagulation in chinese patients with carbomedics mechanical prosthetic heart valves]. Zhuang W; Zhou XM; Hu JG; Li JM; Yu JF; Jiang L; Hu DX Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Aug; 29(4):460-2. PubMed ID: 16134606 [TBL] [Abstract][Full Text] [Related]
6. Experience with moderate intensity anticoagulation and aspirin after mechanical valve replacement. A retrospective, non-randomized study. Albertal J; Sutton M; Pereyra D; Segura EV; Aramburu DF; Lardani H; Diaz R J Heart Valve Dis; 1993 May; 2(3):302-7. PubMed ID: 8269123 [TBL] [Abstract][Full Text] [Related]
7. Reduction of mechanical heart valve thrombosis through a clinical audit. Bharat V; Das NK; Mohanty B; Jha AC; Chawla SC; Dash B; Mohanty R J Heart Valve Dis; 2003 May; 12(3):362-9. PubMed ID: 12803337 [TBL] [Abstract][Full Text] [Related]
8. International normalized ratio self-management lowers the risk of thromboembolic events after prosthetic heart valve replacement. Eitz T; Schenk S; Fritzsche D; Bairaktaris A; Wagner O; Koertke H; Koerfer R Ann Thorac Surg; 2008 Mar; 85(3):949-54; discussion 955. PubMed ID: 18291177 [TBL] [Abstract][Full Text] [Related]
9. LOWERing the INtensity of oral anticoaGulant Therapy in patients with bileaflet mechanical aortic valve replacement: results from the "LOWERING-IT" Trial. Torella M; Torella D; Chiodini P; Franciulli M; Romano G; De Santo L; De Feo M; Amarelli C; Sasso FC; Salvatore T; Ellison GM; Indolfi C; Cotrufo M; Nappi G Am Heart J; 2010 Jul; 160(1):171-8. PubMed ID: 20598989 [TBL] [Abstract][Full Text] [Related]
10. The On-X heart valve: mid-term results in a poorly anticoagulated population. Williams MA; van Riet S J Heart Valve Dis; 2006 Jan; 15(1):80-6. PubMed ID: 16480016 [TBL] [Abstract][Full Text] [Related]
11. Increased sensitivity to warfarin after heart valve replacement. Rahman M; BinEsmael TM; Payne N; Butchart EG Ann Pharmacother; 2006 Mar; 40(3):397-401. PubMed ID: 16507614 [TBL] [Abstract][Full Text] [Related]
12. A randomized trial of patient self-managed versus physician-managed oral anticoagulation. Sunderji R; Gin K; Shalansky K; Carter C; Chambers K; Davies C; Schwartz L; Fung A Can J Cardiol; 2004 Sep; 20(11):1117-23. PubMed ID: 15457308 [TBL] [Abstract][Full Text] [Related]
14. Maternal complications and pregnancy outcome in women with mechanical prosthetic heart valves treated with enoxaparin. McLintock C; McCowan LM; North RA BJOG; 2009 Nov; 116(12):1585-92. PubMed ID: 19681850 [TBL] [Abstract][Full Text] [Related]
15. Low-dose international normalized ratio self-management: a promising tool to achieve low complication rates after mechanical heart valve replacement. Koertke H; Zittermann A; Minami K; Tenderich G; Wagner O; El-Arousy M; Krian A; Ennker J; Taborski U; Klövekorn WP; Moosdorf R; Saggau W; Morshuis M; Koerfer J; Seifert D; Koerfer R Ann Thorac Surg; 2005 Jun; 79(6):1909-14; discussion 1914. PubMed ID: 15919283 [TBL] [Abstract][Full Text] [Related]
16. Low-dose oral anticoagulation in patients with mechanical heart valve prostheses: final report from the early self-management anticoagulation trial II. Koertke H; Zittermann A; Tenderich G; Wagner O; El-Arousy M; Krian A; Ennker J; Taborski U; Klövekorn WP; Moosdorf R; Saggau W; Koerfer R Eur Heart J; 2007 Oct; 28(20):2479-84. PubMed ID: 17890730 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and tolerability of the switch from a branded to a generic warfarin sodium product: an observer-blinded, randomized, crossover study. Lee HL; Kan CD; Yang YJ Clin Ther; 2005 Mar; 27(3):309-19. PubMed ID: 15878384 [TBL] [Abstract][Full Text] [Related]
18. Effect of heart failure exacerbations on anticoagulation: a prospective, observational, pilot cohort study. Ripley TL; Harrison D; Germany RE; Adamson PB Clin Ther; 2010 Mar; 32(3):506-14. PubMed ID: 20399987 [TBL] [Abstract][Full Text] [Related]
19. Optimal level of oral anticoagulant therapy for the prevention of arterial thrombosis in patients with mechanical heart valve prostheses, atrial fibrillation, or myocardial infarction: a prospective study of 4202 patients. Torn M; Cannegieter SC; Bollen WL; van der Meer FJ; van der Wall EE; Rosendaal FR Arch Intern Med; 2009 Jul; 169(13):1203-9. PubMed ID: 19597069 [TBL] [Abstract][Full Text] [Related]
20. German experience with low intensity anticoagulation (GELIA): protocol of a multi-center randomized, prospective study with the St. Jude Medical valve. Horstkotte D; Bergemann R; Althaus U; Babin-Ebell J; Chares M; Dahm M; Eigel P; Elert O; Emmrich K; Geiger AW J Heart Valve Dis; 1993 Jul; 2(4):411-9. PubMed ID: 8269143 [No Abstract] [Full Text] [Related] [Next] [New Search]